Canyam
AI summaries for academic research
Home
Literature Help
Subscribe
Favorites
Tools
Analysis
Summary
Patents
Not logged in
Back
Journal Details
E
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
Papers
65
Citations
Related Insights
0
subscribe
Journal Papers
65
Related Insights
0
Journal Papers
65
Publication Date
Publication Date
IF
Citations
Managing urinary tract infections in pregnancy: teratogenic risks, molecular mechanisms, and antibiotic safety
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-10-04
0
PRE
AI
Biswajeet Acharya; Durga Prasad Mishra; Pallishree Bhukta; Amulyaratna Behera
Share
Save
How close are we to AI-enabled digital biomarkers in clinical toxicology?
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-10-03
0
OA
AI
Federico Goodsaid
Share
Save
Computational approaches to predicting xenobiotic metabolism by the human gut microbiota
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-09-29
0
PRE
AI
Anton S. Kolodnitsky; Alexey A. Lagunin; Vladimir V. Poroikov
Share
Save
Methods of predicting clinically significant DRUG-DRUG interactions beyond validated interaction checkers
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-09-24
0
PRE
AI
Slobodan M. Jankovic; Milijana T. Jovanović; Gorana Nedin Ranković
Share
Save
Population pharmacokinetic/pharmacodynamic modeling of NH600001 reveals age-related differences in sedation response and supports individualized dosing in elderly patients
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-09-17
0
PRE
AI
Ya-Jie Cao; Yun Kuang; Qi Gao; Kun-Hong Deng; Qi Pei; Ya-Xin Liu; Guo-Ping Yang
Share
Save
Pharmacokinetics of novel drugs for the treatment of diabetic nephropathy
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-09-10
0
PRE
AI
Taraneh Mousavi; Fadia T. Shaya; Kashif M. Munir; Stephen N. Davis
Share
Save
Preventing drug interactions with antiretrovirals in the aging HIV population: focusing on population pharmacokinetic modeling
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-09-06
0
PRE
AI
Bailey Thayer; Onyema Ogbuagu
Share
Save
Pharmacologic and clinical considerations of phosphodiesterase type 5 inhibitors and β-adrenergic receptor type 3 agonists for lower urinary tract symptoms and benign prostatic hyperplasia
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-08-28
0
PRE
AI
Eviatar Fields; Dean Elterman; Naeem Bhojani; Jennifer Polo; Bilal Chughtai
Share
Save
Multitask learning in predictive toxicology: methods, benchmarks, and applications
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-08-27
0
PRE
AI
Huixiao Hong; Jie Liu; Wenjing Guo; Tucker A. Patterson
Share
Save
Sex and gender differences in the effects of immunosuppressive drugs in patients with kidney transplantation
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-08-13
0
OA
AI
Claudia Lo Re; Elisa Longhitano; Guido Gembillo; Domenico Santoro
Share
Save
Artificial intelligence in dermatologic pharmacokinetics: quantitative modeling, clinical translation, and optimization of precision therapeutics
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-08-11
0
PRE
AI
Mohamad Goldust
Share
Save
GLP-1RA pharmacokinetics and clinical effects: focus on cardiac, vascular, and glomerular structures
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-08-06
0
PRE
AI
Ivano Barnaba; Francesco Massari; Marco Matteo Ciccone; Pasquale Caldarola; Cosimo Campanella; Gabriella Ricci; Pietro Scicchitano
Share
Save
Inavolisib: a second-generation PI3Kα inhibitor in HR+/HER2-negative breast cancer
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-07-28
0
PRE
AI
Elaria Abdy; Jean-Pierre Betancourt; Supratik Kar
Share
Save
Drug-drug interactions in patients living with HIV and major depression
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-07-15
0
PRE
AI
Ivy Antwi; Theodore J. Cory
Share
Save
An update on beta-lactam–beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant Gram-negative pathogens
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-06-30
0
OA
AI
Ilias Karaiskos; Aikaterini Gkoufa; Evdoxia Kyriazopoulou; Eleni Polyzou; Vasiliki Rapti; Konstantinos Ioannidis; Evangelia Chrysanthopoulou; Zoe Athanassa; Karolina Akinosoglou; Garyphalia Poulakou; null
Share
Save
The use of natural language processing in predictive toxicology
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-06-29
0
OA
AI
Thomas Hartung
Share
Save
Effect of concomitant rifampin and clarithromycin on elexacaftor-tezacaftor-ivacaftor using a physiologically based pharmacokinetic (PBPK) modeling approach
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-06-23
0
PRE
AI
Madeline Sanders; Eunjin Hong; Manya Jain; Paul Beringer
Share
Save
Optimizing tamoxifen therapy in breast cancer: a narrative review of dose escalation in patients with CYP2D6 polymorphisms
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-06-22
0
PRE
AI
Juliana Henrique Duarte; Jose Claudio Casali-da-Rocha; Rafael Linden; Marina Venzon Antunes
Share
Save
Sex differences and impact of age-based menopausal status on tacrolimus pharmacokinetics: results of the TransplantLines Biobank and Cohort study
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-06-15
0
OA
AI
Tanja R. Zijp; Svea Nolte; Tim J. Knobbe; Vincent E. de Meijer; C. Tji Gan; Stephan J.L. Bakker; Iris E. Sommer; Sieta T. de Vries; Daan J. Touw; null
Share
Save
Gastrointestinal bleeding risk among antithrombotics users: a propensity score matched study of drug classes
Expert Opinion on Drug Metabolism & Toxicology
IF
3.4
2026-06-10
0
PRE
AI
Prajwal M. Pradhan; Erich Kummerfeld; Steven Johnson; Gyorgy Simon; Terrence Adam
Share
Save